ライフサイエンスコーパス: central sleep apnea

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 reduced ejection fraction and predominantly central sleep apnea.

2 nts with heart failure to the development of central sleep apnea.

3 esponse to carbon dioxide than those without central sleep apnea (5.1+/-3.1 vs. 2.1+/-1.0 liters per

4 and 20 +/- 27; P = 0.015), the prevalence of central sleep apnea (78% and 39%; P = 0.01), and the mea

5 dose of acetazolamide before sleep improves central sleep apnea and related daytime symptoms.

6 Ten had central sleep apnea, and 10 did not.

7 Forty percent of all patients had central sleep apnea, and 11% had obstructive sleep apnea

8 ng air leaks, patient-ventilator asynchrony, central sleep apnea, and glottic closure.

9 nea appears to have an adverse effect on SV, central sleep apnea appears to have little or slightly p

10 cs have a high prevalence of obstructive and central sleep apnea associated with Cheyne-Stokes respir

11 Central sleep apnea associated with Cheyne-Stokes respir

12 for considering obstructive sleep apnea and central sleep apnea associated with Cheyne-Stokes respir

13 reduced ejection fraction and predominantly central sleep apnea, but all-cause and cardiovascular mo

14 that uses a noninvasive ventilator to treat central sleep apnea by delivering servo-controlled inspi

15 We encountered a young woman with severe central sleep apnea caused by a medullary glioma located

16 aseline sleep indices: apnea-hypopnea index, central sleep apnea (central apnea index, >/=5 vs. <5),

17 rpose of this study was to determine whether central sleep apnea (CSA) contributes to mortality in pa

18 To understand the pathogenesis of central sleep apnea (CSA) in patients with congestive he

19 Central sleep apnea (CSA) is a highly prevalent, though

20 failure (HF) and either obstructive (OSA) or central sleep apnea (CSA).

21 Central sleep apnea frequently occurs in patients with h

22 Patients who met the criteria for central sleep apnea had significantly more episodes of c

23 Patients with central sleep apnea have a diminished cerebrovascular re

24 on abnormality to the presence or absence of central sleep apnea in patients with heart failure.

25 on dioxide contributes to the development of central sleep apnea in some patients with heart failure.

26 the SERVE-HF (Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure) trial res

27 Central sleep apnea, in its various forms, is generally

28 sed whether elevations in the obstructive or central sleep apnea index or the presence of Cheyne-Stok

29 positive predictive value of a low PaCO2 for central sleep apnea is 78%.

30 Central sleep apnea is associated with poor prognosis an

31 of central apnea per hour than those without central sleep apnea (mean [+/-SD], 35+/-24 vs. 0.5+/-1.0

32 Central sleep apnea (odds ratio [OR], 2.58; 95% confiden

33 ep apnea (central apnea index, >/=5 vs. <5), central sleep apnea or Cheyne-Stokes respiration, obstru

34 .18-5.66) and Cheyne-Stokes respiration with central sleep apnea (OR, 2.27; 95% CI, 1.13-4.56), but n

35 ized by fluid overload, both obstructive and central sleep apnea (OSA and CSA) are common.

36 art failure with (n = 9) and without (n = 8) central sleep apnea using transcranial ultrasound during

37 is association persisted after subjects with central sleep apnea were excluded.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。